Intellia Therapeutics Inc (NASDAQ:NTLA)

53.44
Delayed Data
As of Jun 24
 +2.68 / +5.28%
Today’s Change
37.08
Today|||52-Week Range
202.73
-54.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-22.7M-19.1M-21.9M-25.7M
 
 
 
 
 
Depreciation1.2M1.2M1.3M1.3M
 
 
 
 
 
Total Other Cash Flow4.5M3.0M3.4M3.5M
 
 
 
 
 
Funds From Operations-17.1M-14.8M-17.3M-20.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-4.6M-6.3M4.2M6.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-12.5M-8.5M-21.5M-27.7M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-254.6M-19.3M-163.3M
 
 
 
 
Decrease In Investments0.000.0026.5M187.5M
 
 
 
Capital Expenditures-2.0M-1.6M-1.5M-941.0K
 
 
 
 
 
Fixed Asset Disposal--131.0K----
 
 
Net Cash Flow Investing-2.0M-256.0M5.7M23.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale2.2M30.2M4.0M6.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing2.2M30.2M4.0M6.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-12.3M-234.4M-11.8M2.0M